Body mass index and angiotensin-dependent control of the renal circulation in healthy humans

被引:76
作者
Ahmed, SB
Fisher, NDL
Stevanovic, R
Hollenberg, NK
机构
[1] Harvard Univ, Dept Med, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[2] Harvard Univ, Dept Radiol, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
关键词
obesity; hemodynamics; body mass index; renin-angiotensin system; angiotensin II; kidney;
D O I
10.1161/01.HYP.0000190819.07663.da
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Obesity is increasingly recognized as a risk factor for renal disease, but the mechanism is unclear. Renal plasma flow response to captopril, as an index of renin-angiotensin system activity, was measured by para-aminohippurate clearance technique in 100 healthy, normotensive subjects in balance on a high-salt diet. Of the 100 subjects, body mass index exceeded 25 in 56 and exceeded 30 in 22. The average vasodilator response to captopril was 27 +/- 7 mL/min per 1.73 m(2) (P < 0.0001). After adjustment for other predictors of the renal plasma flow response to captopril using a multivariate linear regression model, there was a highly significant relationship between age- and plasma renin activity-adjusted body mass index and the renal plasma flow response to captopril; however, a quadratic model provided a substantially better fit (r = 0.55; P < 0.0001; P = 0.03 versus linear correlation). The strong association between increasing body mass index and angiotensin-dependent control of the renal circulation suggests that this may be a mechanism by which obesity contributes to renal disease. Weight loss should be considered in the overweight or obese patient for renal protection.
引用
收藏
页码:1316 / 1320
页数:5
相关论文
共 45 条
[1]   Annual deaths attributable to obesity in the United States [J].
Allison, DB ;
Fontaine, KR ;
Manson, JE ;
Stevens, J ;
VanItallie, TB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16) :1530-1538
[2]   Hypertension in obese Zucker rats - Role of angiotensin II and adrenergic activity [J].
AlonsoGalicia, M ;
Brands, MW ;
Zappe, DH ;
Hall, JE .
HYPERTENSION, 1996, 28 (06) :1047-1054
[3]   Glomerular filtration rate in severely overweight normotensive humans [J].
Anastasio, P ;
Spitali, L ;
Frangiosa, A ;
Molino, D ;
Stellato, D ;
Cirillo, E ;
Pollastro, RM ;
Capodicasa, L ;
Sepe, J ;
Federico, P ;
De Santo, NG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1144-1148
[4]   Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo -: Evidence for a regulatory role of endothelin [J].
Barton, M ;
Carmona, R ;
Morawietz, HM ;
d'Uscio, LV ;
Goettsch, W ;
Hillen, H ;
Haudenschild, CC ;
Krieger, JE ;
Münter, K ;
Lattmann, T ;
Lüscher, TF ;
Shaw, S .
HYPERTENSION, 2000, 35 (01) :329-336
[5]   Increased renal angiotensin II AT1 receptor function in obese Zucker rat [J].
Becker, M ;
Umrani, D ;
Lokhandwala, MF ;
Hussain, T .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2003, 25 (01) :35-47
[6]   Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis [J].
Bonnet, F ;
Deprele, C ;
Sassolas, A ;
Moulin, P ;
Alamartine, E ;
Berthezène, F ;
Berthoux, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) :720-727
[7]   Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects [J].
Bosma, RJ ;
van der Heide, JJH ;
Oosterop, EJ ;
de Jong, PE ;
Navis, G .
KIDNEY INTERNATIONAL, 2004, 65 (01) :259-265
[8]   DOWN-REGULATION OF THE RENIN-ANGIOTENSIN SYSTEM IN STREPTOZOTOCIN-DIABETIC RATS [J].
CASSIS, LA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (01) :E105-E109
[9]   Glomerular hemodynamics in severe obesity [J].
Chagnac, A ;
Weinstein, T ;
Korzets, A ;
Ramadan, E ;
Hirsch, J ;
Gafter, U .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (05) :F817-F822
[10]   The effects of weight loss on renal function in patients with severe obesity [J].
Chagnac, A ;
Weinstein, T ;
Herman, M ;
Hirsh, J ;
Gafter, U ;
Ori, Y .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06) :1480-1486